Tanishima K, Fukuda N, Takeshita M, Takizawa Y, Kitamura T, Yoneyama Y
J Clin Pathol. 1979 Jun;32(6):584-9. doi: 10.1136/jcp.32.6.584.
A flow diagram for the automated determination of ferricyanide reductase activity in red blood cells was prepared in the modules from AutoAnalyzer AA I (Technicon Instruments Inc). Ferricyanide reductase assay can be substituted for assay of cytochrome b5 reductase (EC 1.6.2.2), which plays a major role in reducing methaemoglobin in erythrocytes, and is defective specifically in the erythrocytes of patients with hereditary methaemoglobinaemia. The effective sampling rate of the analysis is 30/h, and less than 0.05 ml of whole blood is required. Interference of haemoglobin with absorption by potassium ferricyanide at 420 nm is effectively exculded by dialysis. This automated method was compared with the accepted diaphorase method, and it distinguished clearly the ferricyanide reductase activity of cord bloods from that of adult bloods. The activity of the blood from a patient with hereditary methaemoglobinaemia was only residual. It is suggested that the method is useful as a mass screening test for hereditary methaemoglobinaemia.
使用Technicon Instruments Inc公司的AutoAnalyzer AA I模块,绘制了一份自动测定红细胞中氰化铁还原酶活性的流程图。氰化铁还原酶测定可替代细胞色素b5还原酶(EC 1.6.2.2)的测定,细胞色素b5还原酶在红细胞中还原高铁血红蛋白起主要作用,且在遗传性高铁血红蛋白血症患者的红细胞中特异性缺陷。该分析的有效采样率为每小时30次,所需全血少于0.05毫升。通过透析有效排除了血红蛋白对420纳米处铁氰化钾吸收的干扰。将这种自动化方法与公认的黄递酶法进行了比较,它能清楚地区分脐带血和成人血液中氰化铁还原酶的活性。一名遗传性高铁血红蛋白血症患者血液的活性仅为残余水平。建议该方法可作为遗传性高铁血红蛋白血症的大规模筛查试验。